CenTrial Logo

An Effective Treatment for Anxiety Symptoms in Major Depressive Disorder


Clinical trial shows that vortioxetine is effective in reducing anxiety in patients with MDD

People with major depressive disorder (MDD) often experience anxiety symptoms as well. Vortioxetine is a medication that effectively treats anxiety symptoms in patients with MDD. However, it hadn't been fully studied at all the approved dosage levels.

Clinical Study

To address this, researchers conducted several clinical trials to evaluate how well vortioxetine works and how well patients tolerate it. They included data from four different trials where patients with MDD and high levels of anxiety symptoms were given vortioxetine at doses ranging from 5 to 20 mg per day. The researchers also analyzed data from another study that compared vortioxetine (10-20 mg/day) with a medication called agomelatine (25-50 mg/day) in patients who didn't respond well to previous treatments.


Vortioxetine effectively reduced symptoms of depression, anxiety, and overall disability. The higher the dose of vortioxetine, the greater the improvement in these symptoms. Specifically, at a dose of 20 mg per day, vortioxetine showed significant benefits compared to a placebo (a dummy pill with no active ingredient) starting from the fourth week of treatment.

Vortioxetine Vs. Agomelatine

In the study comparing vortioxetine with agomelatine, vortioxetine (10-20 mg/day) was found to be superior to agomelatine in improving symptoms of depression and anxiety, as well as reducing overall disability. These positive effects were seen starting from the fourth week of treatment.

Adverse Effects

The patients tolerated vortioxetine well, and increasing the dose to 20 mg daily did not lead to more side effects. However, it's important to note that the studies were conducted over a relatively short period, so the long-term effects and safety of vortioxetine still need further investigation.

Are you interested in clinical trials near you?

You can receive free notification of a trial for this, or any other condition, by completing a short confidential health profile.
Find a clinical trial near me


Vortioxetine is an effective and well-tolerated medication for patients with MDD and high anxiety levels. It can provide significant benefits in reducing symptoms of depression and anxiety, as well as improving overall functioning. The highest therapeutic benefits were observed at a dose of 20 mg per day. However, it's important for healthcare providers to carefully evaluate each patient's individual needs and consider the potential risks and benefits before prescribing vortioxetine.

Share this article with a friend:

Get emailed clinical trial results in the categories of your choice:
Free subscription to clinical trial results

Without participants there can be no clinical trials.
Without clinical trials there will be no new treatments.
Signup and be matched to trials near you
This free service will notify you of current and future clinical trial matches.

This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition. Assistance from generative AI tools may have been used in writing this article.